New developments in pre-clinical models of ALS to guide translation

Lenja De Cock,Valérie Bercier,Ludo Van Den Bosch
DOI: https://doi.org/10.1016/bs.irn.2024.04.008
2024-04-25
International Review of Neurobiology
Abstract:Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder in which selective death of motor neurons leads to muscle weakness and paralysis. Most research has focused on understanding and treating monogenic familial forms, most frequently caused by mutations in SOD1 , FUS , TARDBP and C9orf72 , although ALS is mostly sporadic and without a clear genetic cause. Rodent models have been developed to study monogenic ALS, but despite numerous pre-clinical studies and clinical trials, few disease-modifying therapies are available. ALS is a heterogeneous disease with complex underlying mechanisms where several genes and molecular pathways appear to play a role. One reason for the high failure rate of clinical translation from the current models could be oversimplification in pre-clinical studies. Here, we review advances in pre-clinical models to better capture the heterogeneous nature of ALS and discuss the value of novel model systems to guide translation and aid in the development of precision medicine.
neurosciences
What problem does this paper attempt to address?